Allscripts-Misys Healthcare Solutions, Inc. (
MDRX) recently entered an agreement with a new client, Parkview Health System, Inc., whereby the latter has selected the Allscripts Electronic Health Record (EHR), Practice Management (PM) and Revenue Cycle Management (RCM) solution. Financial terms of the agreement have not been disclosed.
Parkview Health System has selected Allscripts’ solutions to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery for its employed and affiliated physicians. In addition, Parkview will install the Allscripts Emergency Department Information System (EDIS) to automate administrative and patient care processes in six hospitals.
We think that the new client will help expand Allscripts’ top-line. Parkview Health System is one of Northeast Indiana's largest healthcare providers. Allscripts' EHR is a software that automates the process of writing prescriptions. The EHR system enables physicians to send prescriptions directly to a pharmacy by e-mail. It has been proven that the effective use of EHR systems reduces medical errors, enhances clinical quality and leads to better patient outcomes by providing real-time access to patient records.
The U.S. government is increasingly emphasizing the use of EHR systems these days, as evident from the Medicare Improvements for Patients and Providers Act of 2008. For the first time ever, the Act provides financial incentives to physicians who adopt e-prescribing. The Act requires adoption of this practice by 2011.
Libertyville, IL-based Allscripts Healthcare Solutions Inc. is a leading provider of clinical software and information solutions meant for physicians. In October 2008, the company merged with Misys Plc, global applications software and services company, to form Allscripts−Misys Healthcare Solutions Inc. Allscripts faces strong competition from
Cerner Corp. (
CERN),
Merge Healthcare Inc. (
MRGE),
Quality Systems Inc. (
QSII) and
MedAssets Inc. (
MDAS).
Currently, we are ‘Neutral’ on Allscripts.
Read the full analyst report on "MDRX"
Read the full analyst report on "CERN"
Read the full analyst report on "MRGE"
Read the full analyst report on "QSII"
Read the full analyst report on "MDAS"
Zacks Investment Research
The preceding article is from one of our external contributors.
It does not represent the opinion of Benzinga and has not been edited.
